OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C
OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C Kurs - 1 Jahr
Baader Bank gettex Düsseldorf Lang & Schwarz Stuttgart Tradegate XETRA QuotrixWichtige Stammdaten
Emittent | OSSIAM |
Auflagedatum | 10.11.2017 |
Kategorie | Aktien |
Fondswährung | EUR |
Benchmark | |
Ausschüttungsart | Thesaurierend |
Total Expense Ratio (TER) | 0,17 % |
Fondsgröße | 274.080.899,79 |
Replikationsart | Physisch vollständig |
Morningstar Rating | - |
Anlageziel OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR
So investiert der OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR: The investment objective of the Fund is to replicate, before the Fund's fees and expenses, the performance of the Bloomberg PAB Europe DM ex Eurozone Large & Mid Cap Net Return Index (the “Index”, ticker: EUXPABNL) closing level. The Fund is a financial product that pursuant to Article 9(3) of Regulation (EU) 2019/2088 of the European Parliament and of the Council of 27 November 2019 on sustainability-related disclosures in the financial services sector (the “SFDR”) has the objective of reducing carbon emissions in view of achieving the long-term global warming objectives of the Paris Agreement through the replication of the Index. The Index is a Bloomberg Global Equity Paris-Aligned Index expressed in EUR, calculated and published by Bloomberg (the "Index Provider"). The anticipated level of tracking error in normal conditions is 1.00% over a one-year period.
Der OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR gehört zur Kategorie "Aktien".
Wertentwicklung (NAV) WKN: A2DVG2
3 Monate | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | 2025 | |
---|---|---|---|---|---|---|
Performance | -1,36 % | +3,57 % | +8,13 % | +21,70 % | +69,47 % | +3,97 % |
Outperformance ggü. Kategorie | +1,45 % | +4,48 % | +4,68 % | +5,78 % | +12,56 % | +3,97 % |
Max Verlust | - | - | -10,98 % | -19,21 % | -25,57 % | - |
Kurs | 170,00 € | 162,24 € | 156,94 € | - | - | 167,65 € |
Hoch | - | - | 177,04 € | - | - | - |
Tief | - | - | 146,75 € | - | - | - |
Kennzahlen ISIN: LU1655103486
Name | 1 Jahr | 3 Jahre | 5 Jahre | 10 Jahre |
---|---|---|---|---|
Volatilität | 11,64 % | 13,55 % | 12,77 % | |
Sharpe Ratio | +0,25 | +0,24 | +0,73 |
Zusammensetzung WKN: A2DVG2
Größte Positionen ISIN: LU1655103486
Name | ISIN | Marktkapitalisierung | Gewichtung |
---|---|---|---|
Novo Nordisk AS Class B | DK0062498333 | 273.127.758.279 € | 5,93 % |
Nestle SA | CH0038863350 | 239.583.059.560 € | 5,20 % |
AstraZeneca PLC | GB0009895292 | 195.998.854.725 € | 4,78 % |
Novartis AG Registered Shares | CH0012005267 | 188.158.336.887 € | 4,65 % |
Roche Holding AG | CH0012032048 | 230.846.212.804 € | 4,41 % |
HSBC Holdings PLC | GB0005405286 | 175.609.294.076 € | 4,17 % |
Unilever PLC | GB00B10RZP78 | 140.106.283.498 € | 2,90 % |
RELX PLC | GB00B2B0DG97 | 89.209.063.951 € | 2,05 % |
Compagnie Financiere Richemont SA Class A | CH0210483332 | 90.811.439.302 € | 2,00 % |
Zurich Insurance Group AG | CH0011075394 | 89.786.305.721 € | 1,99 % |
Summe Top 10 | 38,10 % |
Weitere ETFs mit gleicher Benchmark
ETF | TER | Größe | Perf 1J |
---|---|---|---|
OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR | 0,17 % | 274,08 Mio. € | +8,13 % |
Xtrackers II EUR Overnight Rate Swap UCITS ETF 1D | 0,10 % | 17,55 Mrd. € | +3,31 % |
iShares MSCI USA ESG Enhanced CTB UCITS ETF EUR Hedged Acc | 0,10 % | 16,02 Mrd. € | +9,31 % |
Amundi Index Solutions - Amundi EUR Corporate Bond ESG UCITS ETF DR (C) | 0,14 % | 6,11 Mrd. € | +5,31 % |
Vanguard FTSE Developed Europe UCITS ETF | 0,10 % | 4,75 Mrd. € | +8,76 % |